Ratings for Comerica CMA were provided by 16 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 5 | 5 | 3 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 2 | 2 | 0 |
| 2M Ago | 1 | 2 | 1 | 0 | 0 |
| 3M Ago | 1 | 2 | 2 | 1 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $53.03, a high estimate of $70.50, and a low estimate of $43.00. This current average reflects an increase of 8.05% from the previous average price target of $49.08.
Diving into Analyst Ratings: An In-Depth Exploration
The perception of Comerica by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Michael Rose | Raymond James | Raises | Outperform | $62.00 | $48.00 |
| Ryan Nash | Goldman Sachs | Announces | Buy | $70.50 | - |
| Jason Goldberg | Barclays | Raises | Underweight | $59.00 | $49.00 |
| Ryan Nash | Goldman Sachs | Raises | Neutral | $57.00 | $50.00 |
| Whit Mayo | Wells Fargo | Raises | Underweight | $52.00 | $45.00 |
| Steven Alexopoulos | JP Morgan | Announces | Neutral | $57.00 | - |
| Peter Winter | DA Davidson | Raises | Buy | $55.00 | $49.00 |
| Terry McEvoy | Stephens & Co. | Maintains | Overweight | $54.00 | - |
| Ryan Nash | Goldman Sachs | Raises | Neutral | $50.00 | $45.00 |
| Terry McEvoy | Stephens & Co. | Maintains | Overweight | $54.00 | - |
| David Chiaverini | Wedbush | Lowers | Neutral | $45.00 | $47.00 |
| Scott Siefers | Piper Sandler | Lowers | Neutral | $43.00 | $48.00 |
| Jennifer Demba | Truist Securities | Lowers | Buy | $43.00 | $49.00 |
| Michael Rose | Raymond James | Lowers | Outperform | $48.00 | $53.00 |
| Jon Arfstrom | RBC Capital | Lowers | Outperform | $50.00 | $54.00 |
| Jason Goldberg | Barclays | Lowers | Underweight | $49.00 | $52.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Comerica. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Comerica compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Comerica's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Comerica's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Comerica analyst ratings.
Unveiling the Story Behind Comerica
Comerica is a financial services company headquartered in Dallas. It is primarily focused on relationship-based commercial banking. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada.
Financial Milestones: Comerica's Journey
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Comerica's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2023, the company experienced a revenue decline of approximately -9.04%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Comerica's net margin excels beyond industry benchmarks, reaching 27.23%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Comerica's ROE stands out, surpassing industry averages. With an impressive ROE of 4.99%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Comerica's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.28%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Comerica's debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.37, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Analyst Ratings: What Are They?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
